Royal Bank Of Canada Mustang Bio, Inc. Transaction History

Royal Bank Of Canada

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.35 - $0.72 $23 - $47	66 Added 31.13%	278 $0
Q4 2022 Feb 14, 2023	SELL	$0.32 - $8.27 $96 - $2,505	-303 Reduced 58.83%	212 $0
Q3 2022 Nov 14, 2022	BUY	$0.46 - $7.2 $184 - $2,880	400 Added 347.83%	515 $0
Q2 2022 Aug 15, 2022	SELL	$0.58 - $1.13 $2,586 - $5,038	-4,459 Reduced 97.49%	115 $0
Q1 2022 May 16, 2022	SELL	$0.73 - $1.81 $7,852 - $19,470	-10,757 Reduced 70.17%	4,574 $5,000
Q4 2021 Feb 14, 2022	BUY	$1.66 - $2.64 $10,386 - $16,518	6,257 Added 68.96%	15,331 $26,000
Q3 2021 Nov 15, 2021	BUY	$2.58 - $3.36 $10,111 - $13,167	3,919 Added 76.02%	9,074 $25,000
Q2 2021 Aug 16, 2021	BUY	$2.7 - $3.81 $13,918 - $19,640	5,155 New	5,155 $17,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $20M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.